Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Completed × Various Advanced Cancer × Clear all

Phase

Phase 2 2 Phase 3 1

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 490 Neoplasms 251 Prostatic Neoplasms 225 Carcinoma, Non-Small-Cell Lung 221 Colorectal Neoplasms 174 Multiple Myeloma 154 Neoplasm Metastasis 123 Lung Neoplasms 117 Leukemia, Myeloid, Acute 103 Leukemia 97 Lymphoma 96 Lymphoma, Follicular 94 Stomach Neoplasms 87 Lymphoma, Non-Hodgkin 87 Precursor Cell Lymphoblastic Leukemia-Lymphoma 82 Ovarian Neoplasms 79 Rectal Neoplasms 77 Head and Neck Neoplasms 77 Colonic Neoplasms 75 Uterine Cervical Neoplasms 74 Pancreatic Neoplasms 73 Carcinoma, Hepatocellular 73 Leukemia, Lymphocytic, Chronic, B-Cell 72 Pain 71 Melanoma 67 Papillomavirus Infections 58 Lymphoma, Large B-Cell, Diffuse 56 Brain Neoplasms 55 Squamous Cell Carcinoma of Head and Neck 54 Recurrence 54

Interventions

Nivolumab 1 Ipilimumab 1 Fluorouracil 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03143153 2026-02-17

CheckMate 648

Bristol-Myers Squibb

Phase 3 Completed

970 enrolled 15 charts 1 FDA

Various Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡